ORIGEN THERAPEUTICS INC has a total of 24 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, Canada and Australia. Its main competitors in its focus markets biotechnology and agriculture are ORIGEN THERAPEUTICS, TRANXENOGEN INC and BEIJING BIOCYTOGEN CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Canada | 4 | |
#3 | Australia | 3 | |
#4 | Israel | 2 | |
#5 | Japan | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Agriculture |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Animal care | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Etches Robert J | 10 |
#2 | Zhu Lei | 9 |
#3 | Van De Lavoir Marie-Cecile | 7 |
#4 | Zhou Wen | 4 |
#5 | Leighton Philip A | 4 |
#6 | Leighton Philip Albert | 3 |
#7 | Winters-Digiacinto Peggy | 3 |
#8 | Mather Christine | 2 |
#9 | Myers Heather | 2 |
#10 | Philip Albert Leighton | 2 |
Publication | Filing date | Title |
---|---|---|
US2006191026A1 | Tissue specific expression of antibodies in chickens | |
US2006174362A1 | Long-term culture of avian primordial germ cells (PGCs) | |
US2003172387A1 | Tissue specific expression of exogenous proteins in transgenic chickens | |
US2003170888A1 | Chimeric bird from embryonic stem cells | |
US6861572B1 | Production of proteins in eggs |